...
首页> 外文期刊>Open Journal of Internal Medicine >Evolution of Graves’s Disease: Impact of Socio-Demographic and Clinical Factors in Senegalese Subject
【24h】

Evolution of Graves’s Disease: Impact of Socio-Demographic and Clinical Factors in Senegalese Subject

机译:格雷夫斯病的演变:社会人口统计学与临床因素对塞内加尔科目的影响

获取原文

摘要

Background: In Graves’s disease, there is a lack of description specific to the gender and age among sub-Saharan African subject. The objective was to evaluate the impact of gender and age on the profile of Graves’ disease in Senegalese subject in order to understand the evolution and improve the therapeutic choices. Methods: This is a retrospective study conducted from January 1, 2010 to December 31, 2017 (07 years) at Abass Ndao University Hospital (Senegal), focused on patients with Graves’ disease followed up under antithyroid drugs treatment for at least 18 months. Results: There were 244 men, 404 subjects between [0 - 25 years], and 101 subjects more than 50 years old. Factors associated with goitre size were male gender (p < 0.001), young age (p < 0.001). Graves orbitopathy was correlated with male gender (p = 0.015), and young age (p < 0.001). Among 580 patients who had stopped medical treatment after more than 18 months of follow-up, relapse involved in 30.3%. Durable remission was achieved in 38.8% of all included patients and 69.7% of subjects who had a cessation of medical treatment. The factors associated with sustained remission were female gender (p = 0.049), absence of orbitopathy (p = 0.011), small goiter (p < 0.001), advanced age (p = 0.006) and early start of the maintenance treatment (p = 0.006). Conclusion: In our Senegalese study, men and young patients are particularized by a trend of voluminous goitre and low rate of remission. These data remain a basis for predicting the outcome of medical treatment and make timely use of radical treatments such as surgery or irratherapy in the presence of risk factors for recurrence.
机译:背景:在Graves的疾病中,撒哈拉以南非洲科目中的性别和年龄缺乏描述。目的是评估性别和年龄对塞内加尔科目的坟墓疾病概况的影响,以了解进化和改善治疗选择。方法:这是从2010年1月1日至2017年12月31日(07年)在Abass Ndao大学医院(塞内加尔)进行的回顾性研究,重点关注患有Graves疾病的患者,随访于抗胆汁药物治疗至少18个月。结果:在[0 - 25岁]之间有244名男性,404名科目,101名受试者超过50岁。与GoItre大小相关的因素是男性性别(P <0.001),年轻(P <0.001)。 Graves胰腺炎与男性性别(P = 0.015)和幼年龄(P <0.001)相关联。在580名患者中,在超过18个月后停止医疗后的后续后,复发涉及30.3%。耐用的缓解是在38.8%的所有患者中获得的,69.7%的受试者遭到停止治疗。与缓解缓解相关的因素是女性性别(P = 0.049),没有胰胰腺病(P = 0.011),小甲状腺肿(P <0.001),晚期(P = 0.006)和早期开始进行维持治疗(P = 0.006 )。结论:在我们的塞内加尔学习中,男女患者是巨大的巨大的潮流和低残留率的趋势。这些数据仍然是预测治疗结果的基础,并及时使用在危险因素的情况下进行手术或Irraterapy等自由基处理,以进行复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号